New Heart Failure Study Results from Lund University Described (Selenium, selenoprotein P and autoantibodies to selenium transport proteins in Swedish heart failure patients - a pilot study in preparation for a randomized supplementation trial).

A recent study conducted at Lund University in Sweden found a high prevalence of suboptimal selenium status in Swedish heart failure patients, with up to 70% of patients having selenium deficiency. The study also identified the presence of autoantibodies to selenoprotein P, which may disrupt transportation mechanisms. The researchers suggest that large, well-designed randomized controlled trials are needed to assess the efficacy and safety of selenium supplementation as a potential treatment option for heart failure patients. [Extracted from the article]